
Results
181
Companies which are potentially undervalued and in an acceptable financial position.
181 companies
High Tide
Market Cap: CA$278.1m
Engages in the cannabis retail business in Canada, the United States, and internationally.
HITI
CA$3.18
7D
10.6%
1Y
5.1%
TG Therapeutics
Market Cap: US$6.9b
A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.
TGTX
US$49.88
7D
-6.7%
1Y
80.1%
Innovent Biologics
Market Cap: HK$157.2b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.
1801
HK$90.30
7D
0.7%
1Y
-7.9%
Kissei Pharmaceutical
Market Cap: JP¥161.9b
Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.
4547
JP¥3,905.00
7D
-9.9%
1Y
-13.2%
Arcutis Biotherapeutics
Market Cap: US$3.3b
A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
ARQT
US$27.10
7D
-2.7%
1Y
76.4%
CorMedix
Market Cap: US$590.0m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$7.41
7D
3.1%
1Y
-38.0%
United Therapeutics
Market Cap: US$22.2b
Engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.
UTHR
US$519.34
7D
-1.0%
1Y
71.7%
Hypera
Market Cap: R$15.2b
Operates as a pharmaceutical company in Brazil.
HYPE3
R$21.46
7D
2.0%
1Y
-14.7%
Yunnan Baiyao GroupLtd
Market Cap: CN¥90.8b
Engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China.
000538
CN¥50.90
7D
-1.9%
1Y
-9.0%
Hugel
Market Cap: ₩2.8t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩260,000.00
7D
13.3%
1Y
-24.0%
Green Thumb Industries
Market Cap: CA$2.2b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$9.31
7D
-4.0%
1Y
-1.8%
UCB
Market Cap: €43.7b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€229.20
7D
-8.6%
1Y
25.4%
Kuros Biosciences
Market Cap: CHF 928.3m
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
KURN
CHF 23.40
7D
-0.6%
1Y
-14.7%
Supernus Pharmaceuticals
Market Cap: US$2.5b
A biopharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States.
SUPN
US$46.91
7D
0.7%
1Y
10.5%
Dong-E-E-Jiao
Market Cap: CN¥34.6b
Engages in the research, development, production, and sale of donkey-hide gelatin and related products in China and internationally.
000423
CN¥54.25
7D
0.8%
1Y
5.8%
Shionogi
Market Cap: JP¥2.3t
Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.
4507
JP¥2,758.00
7D
-10.2%
1Y
5.0%
Bavarian Nordic
Market Cap: DKK 13.7b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 179.30
7D
1.4%
1Y
-24.0%
Fine Foods & Pharmaceuticals N.T.M
Market Cap: €193.8m
Fine Foods & Pharmaceuticals N.T.M. S.p.A.
FF
€8.24
7D
1.0%
1Y
-1.0%
Ardelyx
Market Cap: US$1.2b
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX
US$4.91
7D
-1.8%
1Y
-5.6%
Prestige Consumer Healthcare
Market Cap: US$2.5b
Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.
PBH
US$52.98
7D
1.5%
1Y
-29.5%
Diaceutics
Market Cap: UK£122.8m
A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.
DXRX
UK£1.45
7D
9.8%
1Y
5.5%
Dong-A ST
Market Cap: ₩358.6b
Develops, manufactures, and markets pharmaceutical products in South Korea and internationally.
A170900
₩37,200.00
7D
10.7%
1Y
-15.1%
Amoy Diagnostics
Market Cap: CN¥6.8b
Engages in research and development, production, sale, and supporting services of tumor precision medical diagnostic products in China and internationally.
300685
CN¥17.72
7D
2.4%
1Y
-25.1%
Journey Medical
Market Cap: US$176.2m
A commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
DERM
US$6.40
7D
4.1%
1Y
-11.5%
Decibel Cannabis
Market Cap: CA$63.5m
An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.
DB
CA$0.10
7D
0%
1Y
23.5%
Fennec Pharmaceuticals
Market Cap: US$351.2m
Operates as a commercial stage biopharmaceutical company in the United States.
FENC
US$10.52
7D
9.0%
1Y
28.9%
United Laboratories International Holdings
Market Cap: HK$18.0b
An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.
3933
HK$9.13
7D
-0.7%
1Y
-37.9%
Daewoong Pharmaceutical
Market Cap: ₩1.4t
Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
A069620
₩124,500.00
7D
2.0%
1Y
-8.7%
China Resources Pharmaceutical Group
Market Cap: HK$30.4b
An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.
3320
HK$4.85
7D
-1.1%
1Y
-8.2%
Dermapharm Holding
Market Cap: €2.0b
Manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China.
DMP
€41.15
7D
-4.0%
1Y
28.0%
Perrigo
Market Cap: US$1.5b
Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.
PRGO
US$13.27
7D
27.2%
1Y
-43.8%
Laboratorios Farmaceuticos Rovi
Market Cap: €3.0b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€58.65
7D
-1.5%
1Y
12.8%
Clinuvel Pharmaceuticals
Market Cap: AU$470.5m
A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.
CUV
AU$9.33
7D
-2.7%
1Y
-24.0%
Otsuka Holdings
Market Cap: JP¥6.2t
Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.
4578
JP¥11,805.00
7D
2.6%
1Y
56.0%
Tasly Pharmaceutical Group
Market Cap: CN¥23.5b
Engages in the research, development, production, and sale of pharmaceuticals in China.
600535
CN¥15.72
7D
-1.4%
1Y
-4.2%
Takeda Pharmaceutical
Market Cap: JP¥8.4t
Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products.
4502
JP¥5,269.00
7D
-9.9%
1Y
24.3%